Compound information
- Natural Products
- ZC2119433
- Molecular Formula
- C19H23N3O
- Molecular Weight
- 309.184112356 g/mol
- Structure
-
- IUPAC Name
- N-(m-tolyl)-4-(3-pyridylmethyl)piperidine-1-carboxamide
- InChI
- InChI=1S/C19H23N3O/c1-15-4-2-6-18(12-15)21-19(23)22-10-7-16(8-11-22)13-17-5-3-9-20-14-17/h2-6,9,12,14,16H,7-8,10-11,13H2,1H3,(H,21,23)
- InChI Key
- IZEGULFYKXFUNZ-UHFFFAOYSA-N
- SMILES
- Cc1cccc(NC(=O)N2CCC(Cc3cccnc3)CC2)c1
- Source
- ZINC000253418075
Warheads
- Urea carbonyl
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 23 | Ring Count | 3 |
Heteroatom Count | 4 | Rotatable Bond Count | 3 |
Hydrogen Bond Acceptor Count | 2 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 45.23 Å2 | LogP | 3.707 |
LogS | -3.321 | LogD | 3.729 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.583 | Pgp substrate | 0.167 |
HIA | 0.965 | F20 % | 0.993 |
F30 % | 0.954 | Caco-2 | -4.752 |
MDCK | -5.166 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.139 | PPB | 95.444 |
VD | 0.815 | Fu | 1.227 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.595 | CYP1A2 substrate | 0.781 |
CYP2A6 substrate | 0.726 | CYP2B6 substrate | 0.657 |
CYP2C19 inhibitor | 0.977 | CYP2C19 substrate | 0.911 |
CYP2C8 substrate | 0.775 | CYP2C9 inhibitor | 0.818 |
CYP2C9 substrate | 0.122 | CYP2D6 inhibitor | 0.845 |
CYP2D6 substrate | 0.994 | CYP2E1 substrate | 0.802 |
CYP3A4 inhibitor | 0.913 | CYP3A4 substrate | 0.979 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.64 | CL | 10.259 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.976 | Hepatotoxicity | 0.889 |
Mutagenicity | 0.001 | Rat Oral Acute Toxicity | 0.027 |
FDAMDD | 0.607 | Skin Sensitization | 1.0 |
Carcinogenicity | 0.009 | Eye Corrosion | 0.002 |
Eye Irritation | 0.004 | Respiratory Toxicity | 0.155 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.908 | IGC50 | 3.809 |
LC50FM | 3.901 | LC50DM | 3.917 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.174 | NR-AR-LBD | 0.177 |
NR-AhR | 0.619 | NR-Aromatase | 0.847 |
NR-ER | 0.316 | NR-ER-LBD | 0.284 |
NR-PPAR-gamma | 0.332 | SR-ARE | 0.797 |
SR-ATAD5 | 0.486 | SR-HSE | 0.364 |
SR-MMP | 0.881 | SR-p53 | 0.06 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.